tiprankstipranks
Trending News
More News >
Oppenheimer bullish on Nurix as Sanofi opt-in, competitor data derisk STAT6
PremiumThe FlyOppenheimer bullish on Nurix as Sanofi opt-in, competitor data derisk STAT6
27d ago
Analyst Recommends ‘Buy’ for Nurix Therapeutics Amid Strong Endorsement and Promising STAT6 Program
Premium
Ratings
Analyst Recommends ‘Buy’ for Nurix Therapeutics Amid Strong Endorsement and Promising STAT6 Program
27d ago
Sanofi exercises license extension option to Nurix’s STAT6 program
Premium
The Fly
Sanofi exercises license extension option to Nurix’s STAT6 program
28d ago
Nurix Therapeutics announces FDA cleared the IND for GS-6791/NX-0479
PremiumThe FlyNurix Therapeutics announces FDA cleared the IND for GS-6791/NX-0479
2M ago
Top 3 Trending Stocks, According to Analysts – 4/11/2025
Premium
Market News
Top 3 Trending Stocks, According to Analysts – 4/11/2025
3M ago
Cautious Outlook on Nurix Therapeutics Amid Promising Pipeline and Development Uncertainties
Premium
Ratings
Cautious Outlook on Nurix Therapeutics Amid Promising Pipeline and Development Uncertainties
3M ago
Nurix Therapeutics price target lowered to $25 from $32 at Wells Fargo
PremiumThe FlyNurix Therapeutics price target lowered to $25 from $32 at Wells Fargo
3M ago
Nurix Therapeutics price target lowered to $35 from $36 at Stifel
Premium
The Fly
Nurix Therapeutics price target lowered to $35 from $36 at Stifel
3M ago
Nurix Therapeutics: Strong Financials and Strategic Collaborations Support ‘Buy’ Rating
Premium
Ratings
Nurix Therapeutics: Strong Financials and Strategic Collaborations Support ‘Buy’ Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100